Novel medicinal composition and preparation method
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of composition and medicine, which is applied in the field of new pharmaceutical composition and preparation, can solve the problems of weak inductive ability, achieve the effects of reducing dosage, low treatment cost and increasing anti-lung cancer effect
Inactive Publication Date: 2010-10-06
天津泽世德生物医药有限公司
View PDF1 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Astragalus polysaccharide alone can induce the production of endogenous interferon, but the induction ability is weak; Newcastle disease virus has a significant effect on inducing interferon-α; the combination of astragalus polysaccharide and Newcastle disease virus has a stronger induction ability, resulting in a synergistic effect, far higher for separate use
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
specific Embodiment 1
[0029] (1) Selection and cultivation of chicken Newcastle disease virus
[0030] Chicken Newcastle disease virus is selected, cultured in the allantoic fluid of 10-12 day old live chicken embryos at 37-38° C. for 48-72 hours, and then the allantoic fluid containing the virus is collected.
[0031] The titer was determined by the hemagglutination method, and then the titer of the chicken Newcastle disease virus allantoic fluid determined was adjusted to 1:640.
[0032] The impurities, protein, contaminated bacteria and part of urate in the allantoic fluid of chicken embryos are removed through a closed double-layer poplin bag and a 0.22 μm microporous membrane filter.
[0033] (2) Preparation of preparation components
[0034] A: Glycoprotein G 1 0.72 g Glycoprotein G 2 0.36 grams
[0035] Dissolve in 160 ml of 0.075NHCL solution in sequence, and place in a water bath for half an hour.
[0036] B: Biotin 1.0mg
[0037] Dissolve in 7.5 ml of deionized water first, add 0.1 ...
specific Embodiment 2
[0069] (1) Selection and cultivation of chicken Newcastle disease virus
[0070] Chicken Newcastle disease virus is selected, cultured in the allantoic fluid of 10-12 day old live chicken embryos at 37-38° C. for 48-72 hours, and then the allantoic fluid containing the virus is collected.
[0071] The titer was determined by the hemagglutination method, and then the titer of the chicken Newcastle disease virus allantoic fluid determined was adjusted to 1:640.
[0072] The impurities, protein, contaminated bacteria and part of urate in the allantoic fluid of chicken embryos are removed through a closed double-layer poplin bag and a 0.22 μm microporous membrane filter.
[0073] (2) Preparation of preparation components
[0074] A: Glycoprotein G 1 0.72 g Glycoprotein G 2 0.36 grams
[0075] Dissolve in 160 ml of 0.075NHCL solution in sequence, and place in a water bath for half an hour.
[0076] B: Biotin 1.0 mg
[0077] Dissolve in 7.5 ml of deionized water first, add 0.1...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a novel medicinal composition for improving organism immune function and resisting tumor to address both the symptoms and root cause, and a preparation method. The medicinal composition comprises the following components: 1,500 milliliters of Newcastle disease virus allantoic fluid with a titer of 1:640, 2 milliliters of neuraminidase, 2 milliliters of nuclease, 1.08 grams of glycoprotein G, 10 grams of galactose, 1.0 milligrams of biotin, 5 grams of fucose, 15 grams of astragalus polysaccharide, 2.0 milligrams of sialidase, 2.0 milligrams of phospholipid, 10 milligrams of uracil, 5 milligrams of Vit C, 4.0 milligrams of cholesterol, 200 milligrams of ATP, 22 milliliters of 10 percent KCl, 3.6 grams of MgSO4.7H2O, and 10 milligrams of prothrombin. The experiments for pharmacodynamics, pharmacology and the like, show that the medicinal composition has good inhibiting and killing effects on mouse transplantable tumor such as Lewis lung carcinoma. Compared with the medicament of the conventional invention, the medicinal composition has more remarkable diffidence in the growth inhibiting effect on the mouse Lewis lung carcinoma. The medicinal composition has obvious effect, and is a novel biological anticancer preparation with good social and economic benefits.
Description
technical field [0001] The invention relates to a new anticancer drug composition with high efficiency and broad spectrum and a preparation method. The pharmaceutical composition prepared by the invention has more obvious therapeutic effect on cancers such as lung cancer. Background technique [0002] Drugs with high anti-tumor effect and low side effects have not been found yet. Macrophages, cytotoxicity, T lymphocytes, natural killer cells, hybridoma cells secreting monoclonal antibodies, interleukins, interferons, tumor necrosis factors, immunoglobulins and other cytotoxic active cells produced by modern cell engineering technology And cytokines, their common role is mainly adoptive immunity, in order to achieve the purpose of anti-tumor. [0003] The DNA polymerase and RNA polymerase activities of cancer cells are higher than normal cells, so the synthesis of nucleic acid by cancer cells is enhanced. In contrast, the decomposition process of cancer cell nucleic acid w...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more